These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27525858)

  • 41. Association of MTHFR 677T variant allele with risk of intracerebral haemorrhage: a meta-analysis.
    Gao S; Li H; Xiao H; Yao G; Shi Y; Wang Y; Zhou X; Yu H
    J Neurol Sci; 2012 Dec; 323(1-2):40-5. PubMed ID: 22938732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis.
    Lee YH; Choi SJ; Ji JD; Song GG
    Lupus; 2012 Jul; 21(8):865-71. PubMed ID: 22399073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of promoter polymorphism -857C/T (rs1799724) in tumor necrosis factor gene with intracerebral hemorrhage in Korean males.
    Park HJ; Kim SK; Park HK; Chung JH
    Neurol Res; 2017 Jan; 39(1):90-95. PubMed ID: 27809686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.
    Attié-Castro FA; Zago MA; Lavinha J; Elion J; Rodriguez-Delfin L; Guerreiro JF; Franco RF
    Thromb Haemost; 2000 Oct; 84(4):601-3. PubMed ID: 11057857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model.
    Kovar FM; Marsik CL; Jilma B; Mannhalter C; Joukhadar C; Wagner OF; Endler G
    Wien Klin Wochenschr; 2009; 121(15-16):515-9. PubMed ID: 19787322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A.
    Wartiovaara U; Mikkola H; Szôke G; Haramura G; Kárpáti L; Balogh I; Lassila R; Muszbek L; Palotie A
    Thromb Haemost; 2000 Oct; 84(4):595-600. PubMed ID: 11057856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
    Shemirani AH; Antalfi B; Pongrácz E; Mezei ZA; Bereczky Z; Csiki Z
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):364-8. PubMed ID: 24686102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor XIII-A Val34Leu polymorphism might beassociated with myocardial infarction risk: an updated meta-analysis.
    Wang G; Zou Z; Ji X; Ni Q; Ma Z
    Int J Clin Exp Med; 2014; 7(12):5547-52. PubMed ID: 25664069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
    Yao L; Fang F; Wu Q; Zhong Y; Yu L
    Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis.
    Kim SD; Hwang JK; Park SC; Kim JI; Won YS; Yun SS; Moon IS; Park JS
    Ann Vasc Surg; 2016 Apr; 32():57-64. PubMed ID: 26802299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage.
    Elmahgoub IR; Afify RA; Abdel Aal AA; El-Sherbiny WS
    J Reprod Immunol; 2014 Jun; 103():18-22. PubMed ID: 24702949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meta-Analysis of Factor V, Factor VII, Factor XII, and Factor XIII-A Gene Polymorphisms and Ischemic Stroke.
    Wei LK; Griffiths LR; Kooi CW; Irene L
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30979054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.
    Bronić A; Ferencak G; Zadro R; Stavljenić-Rukavina A; Bernat R
    Mol Biol Rep; 2009 Jan; 36(1):1-5. PubMed ID: 17899444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
    Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of association between FXIII-Val34Leu, FVII-323 del/ins, and transforming growth factor beta1 (915G/T) gene polymorphisms and bronchopulmonary dysplasia: a single-center study.
    Ataç FB; Ince DA; Verdi H; Gökmen Z; Yazici AC; Gülcan H; Tarcan A; Taneri A; Sezgin E; Ozbek N
    DNA Cell Biol; 2010 Jan; 29(1):13-8. PubMed ID: 19778283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of the beta1-tubulin Q43P polymorphism with intracerebral hemorrhage in men.
    Navarro-Núñez L; Lozano ML; Rivera J; Corral J; Roldán V; González-Conejero R; Iniesta JA; Montaner J; Vicente V; Martínez C
    Haematologica; 2007 Apr; 92(4):513-8. PubMed ID: 17488662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meta-analysis reveals a lack of association between a common catechol-O-methyltransferase (COMT) polymorphism val¹⁵⁸met and fibromyalgia.
    Zhang L; Zhu J; Chen Y; Zhao J
    Int J Clin Exp Pathol; 2014; 7(12):8489-97. PubMed ID: 25674213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.